512-07-2 Usage
General Description
Sarsasapogenone is a natural steroidal sapogenin compound found in various plants, particularly in the sarsaparilla root. It is a natural precursor to the synthesis of various steroid hormones, such as estrogen and progesterone. Sarsasapogenone has been studied for its potential medicinal properties, including anti-inflammatory, antioxidant, and anti-cancer effects. It has also been used in the production of cosmetic products due to its ability to promote skin hydration and elasticity. Additionally, sarsasapogenone has shown promising effects on promoting hair growth and reducing hair loss, making it a potential ingredient in hair care products. Overall, sarsasapogenone has shown potential in various fields, from medicine to cosmetics, and continues to be studied for its diverse range of potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 512-07-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,1 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 512-07:
(5*5)+(4*1)+(3*2)+(2*0)+(1*7)=42
42 % 10 = 2
So 512-07-2 is a valid CAS Registry Number.
InChI:InChI=1/C27H42O3/c1-16-7-12-27(29-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(28)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-18,20-24H,5-15H2,1-4H3/t16-,17+,18-,20-,21+,22+,23+,24+,25+,26+,27-/m1/s1
512-07-2Relevant articles and documents
Diosgenin derivatives, and pharmaceutical compositions thereof and application thereof
-
Paragraph 0108-0110; 0112, (2019/01/24)
The invention relates to diosgenin derivatives. The structural formula of the diosgenin derivatives is as shown in a general formula (1) which is described in the specification. The invention also provides pharmaceutical compositions of the diosgenin derivatives and application thereof. According to the invention, systematic structural modification directed at double bonds at position 3 and position 5/6 of a lead compound is performed for the first time so as to synthesize a series of novel compounds; and the results of activity tests of the novel compounds at related targets show that most ofthe novel compounds have better activity than the activity of the lead compound and are very valuable for the treatment of neurodegenerative diseases. Thus, the diosgenin derivatives overcome defectsof conventional diosgenin derivatives and have important significance.
